These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9566054)

  • 1. EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.
    Skuza G; Rogóz Z; Gołembiowska K
    Pol J Pharmacol; 1997; 49(6):489-93. PubMed ID: 9566054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system.
    Maj J; Kołodziejczyk K; Rogóz Z; Skuza G
    Pharmacopsychiatry; 1997 Mar; 30(2):55-61. PubMed ID: 9131725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
    Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system.
    Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E
    Pol J Pharmacol; 2000; 52(3):209-16. PubMed ID: 11055578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization of pre and post synaptic 5-HT-1A receptor responses following long term consumption of sugar rich diet: implications for sugar-induced obesity.
    Jabeen B; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):327-32. PubMed ID: 18930850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine.
    Skuza G; Gołembiowska K; Wedzony K
    Pol J Pharmacol; 1998; 50(1):61-4. PubMed ID: 9662740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction between 5-HT1B and 5-HT1A or 5-HT2 receptors in mice.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(3):251-60. PubMed ID: 1470563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
    Celik T; Gören MZ; Cinar K; Gürdal H; Onder FO; Tan A; Terzioğlu B; Bozdayi AM; Bozkaya H; Uzunalimoğlu O; Yurdaydin C
    Hepatology; 2005 Apr; 41(4):731-7. PubMed ID: 15726642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
    Tam SW; Steinfels GF; Gilligan PJ; Schmidt WK; Cook L
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1167-74. PubMed ID: 1361572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated treatment with oxaprotiline enantiomers on central 5-HT receptor subpopulations.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(2):133-50. PubMed ID: 8401766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study.
    Müller CP; Thönnessen H; De Souza Silva MA; Fink H; Bert B; Carey RJ; Huston JP
    Neuropharmacology; 2004 Aug; 47(2):205-15. PubMed ID: 15223299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of oxaprotiline enantiomers on the central serotonin system.
    Maj J; Dereń A; Moryl E
    Pol J Pharmacol Pharm; 1989; 41(4):345-57. PubMed ID: 2534522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.